These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 33996776)

  • 1. Advances in Synthetic Biology and Biosafety Governance.
    Li J; Zhao H; Zheng L; An W
    Front Bioeng Biotechnol; 2021; 9():598087. PubMed ID: 33996776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's evolving biosafety/biosecurity legislations.
    Cao C
    J Law Biosci; 2021; 8(1):lsab020. PubMed ID: 34221436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety risks and ethical governance of biomedical applications of synthetic biology.
    Ou Y; Guo S
    Front Bioeng Biotechnol; 2023; 11():1292029. PubMed ID: 37941726
    [No Abstract]   [Full Text] [Related]  

  • 4. Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.
    Xue Y; Shang L
    Front Bioeng Biotechnol; 2022; 10():939295. PubMed ID: 35860327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facing the 2020 pandemic: What does cyberbiosecurity want us to know to safeguard the future?
    Mueller S
    Biosaf Health; 2021 Feb; 3(1):11-21. PubMed ID: 33015604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building biosecurity for synthetic biology.
    Trump BD; Galaitsi SE; Appleton E; Bleijs DA; Florin MV; Gollihar JD; Hamilton RA; Kuiken T; Lentzos F; Mampuys R; Merad M; Novossiolova T; Oye K; Perkins E; Garcia-Reyero N; Rhodes C; Linkov I
    Mol Syst Biol; 2020 Jul; 16(7):e9723. PubMed ID: 32692486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and management of the biosecurity for synthetic biology.
    Zeng X; Jiang H; Yang G; Ou Y; Lu S; Jiang J; Lei R; Su L
    Synth Syst Biotechnol; 2022 Jun; 7(2):784-790. PubMed ID: 35387231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving U.S. Biosafety and Biosecurity: Revisiting Recommendations from the Federal Experts Security Advisory Panel and the Fast Track Action Committee on Select Agent Regulations.
    Haines CA; Gronvall GK
    Appl Biosaf; 2023 Mar; 28(1):43-54. PubMed ID: 36895583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus.
    Gao P; Ma S; Lu D; Mitcham C; Jing Y; Wang G
    Synth Syst Biotechnol; 2020 Jun; 5(2):59-61. PubMed ID: 32296735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical and regulatory challenges posed by synthetic biology.
    Rager-Zisman B
    Perspect Biol Med; 2012; 55(4):590-607. PubMed ID: 23502567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future trends in synthetic biology in Asia.
    Mao N; Aggarwal N; Poh CL; Cho BK; Kondo A; Liu C; Yew WS; Chang MW
    Adv Genet (Hoboken); 2021 Mar; 2(1):e10038. PubMed ID: 36618442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical and social insights into synthetic biology: predicting research fronts in the post-COVID-19 era.
    Wang G; Kong Q; Wang D; Asmi F
    Front Bioeng Biotechnol; 2023; 11():1085797. PubMed ID: 37274167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making Security Viral: Shifting Engineering Biology Culture and Publishing.
    Mackelprang R; Adamala KP; Aurand ER; Diggans JC; Ellington AD; Evans SW; Fortman JLC; Hillson NJ; Hinman AW; Isaacs FJ; Medford JI; Mamaghani S; Moon TS; Palmer MJ; Peccoud J; Vitalis EA; Hook-Barnard I; Friedman DC
    ACS Synth Biol; 2022 Feb; 11(2):522-527. PubMed ID: 35176864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The whack-a-mole governance challenge for AI-enabled synthetic biology: literature review and emerging frameworks.
    Undheim TA
    Front Bioeng Biotechnol; 2024; 12():1359768. PubMed ID: 38481570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review.
    Ahmad T; Haroon ; Dhama K; Sharun K; Khan FM; Ahmed I; Tiwari R; Musa TH; Khan M; Bonilla-Aldana DK; J Rodriguez-Morales A; Hui J
    Turk J Biol; 2020; 44(3):132-145. PubMed ID: 32595350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety by design: Biosafety and biosecurity in the age of synthetic genomics.
    Hoffmann SA; Diggans J; Densmore D; Dai J; Knight T; Leproust E; Boeke JD; Wheeler N; Cai Y
    iScience; 2023 Mar; 26(3):106165. PubMed ID: 36895643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombination between coronaviruses and synthetic RNAs and biorisk implications motivated by a SARS-CoV-2 FCS origin controversy.
    Mueller S
    Front Bioeng Biotechnol; 2023; 11():1209054. PubMed ID: 37600318
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.